← CorMedix Inc. CRMD
Market Price
$7.55
Market Cap
$638.60M
P/E Ratio
3.70
Revenue (FY 2025)
↑617.0% YoY
$311.71M
3-Yr CAGR: 1,582.8%
Net Income
↑1,009.4% YoY
$163.06M
Net Margin: 52.3%
Free Cash Flow
↑440.6% YoY
$172.79M
FCF Yield: 27.06%
EPS (Diluted)
↑780.0% YoY
$2.04
Basic: $2.25
Return on Equity
Efficiency
40.2%
ROA: 928.0%
📊 Multi-Year Historical Performance & Trends
Financial Performance History
Revenue, Net Income & Free Cash Flow
Margins Trend (%)
Gross, Operating & Net Margins
Balance Sheet Strength
Cash, Debt & Equity
Cash Flow Generation
Operating Cash Flow vs CapEx vs FCF
📈 Year-over-Year (YoY) Growth History (CRMD)
All monetary values in millions ($M)| Fiscal Year | Revenue | Revenue YoY | Gross Profit | Net Income | Net Inc YoY | Diluted EPS | EPS YoY | Op. Cash Flow | Free Cash Flow | FCF YoY |
|---|---|---|---|---|---|---|---|---|---|---|
| FY 2016 | $0.2M | — | $-0.1M | $-24.6M | — | $-0.65 | — | $-22.3M | $-22.3M | — |
| FY 2017 | $0.3M | +47.0% | $0.2M | $-33.0M | -33.9% | $-0.60 | +7.7% | $-28.6M | $-28.7M | -28.7% |
| FY 2018 | $0.4M | +30.5% | $0.0M | $-26.8M | +18.7% | $-1.51 | -151.7% | $-23.7M | $-23.7M | +17.4% |
| FY 2019 | $0.3M | -34.1% | $-0.1M | $-16.4M | +38.8% | $-1.80 | -19.2% | $-15.1M | $-15.1M | +36.5% |
| FY 2020 | $0.2M | -15.5% | $0.0M | $-22.0M | -34.0% | $-0.77 | +57.2% | $-22.0M | $-22.1M | -46.3% |
| FY 2021 | $0.2M | -20.2% | $0.0M | $-28.2M | -28.1% | $-0.75 | +2.6% | $-21.2M | $-22.6M | -2.3% |
| FY 2022 | $0.1M | -65.7% | $0.0M | $-29.7M | -5.3% | $-0.74 | +1.3% | $-24.4M | $-24.6M | -8.8% |
| FY 2023 | $2.7M | +4,000.2% | $0.7M | $-46.3M | -56.0% | $-0.91 | -23.0% | $-38.4M | $-38.7M | -57.6% |
| FY 2024 | $43.5M | +1,521.0% | $40.3M | $-17.9M | +61.3% | $-0.30 | +67.0% | $-50.6M | $-50.7M | -31.0% |
| FY 2025 | $311.7M | +617.0% | $289.6M | $163.1M | +1,009.4% | $2.04 | +780.0% | $175.0M | $172.8M | +440.6% |
Valuation
Market Price
$7.55
Market Cap
$638.60M
Enterprise Value
N/A
P/E Ratio
3.70
P/B Ratio
1.46
FCF Yield
27.06%
Dividend Yield
N/A
Shares Outstanding
Profitability & Margins
Gross Margin
92.91%
Operating Margin
48.17%
Net Margin
52.31%
Return on Equity (ROE)
40.23%
Return on Assets (ROA)
927.98%
Asset Turnover
17.74x
Revenue 3-Yr CAGR
1,582.83%
Financial Health & Liquidity
Current Ratio
0.11
Cash Ratio
0.89
Debt / Equity
N/A
Debt / Assets
N/A
Cash & Equivalents
$144.84M
Total Debt
N/A
Book Value / Share
$5.17
Cash Flow Efficiency
Operating Cash Flow
$175.05M
Capital Expenditures (CapEx)
$2.26M
Free Cash Flow
$172.79M
OCF / Revenue
56.16%
FCF / Revenue
55.43%
FCF 3-Yr CAGR
N/A
Per Share Metrics
EPS (Diluted)
$2.04
EPS (Basic)
$2.25
Dividends / Share
N/A
Book Value / Share
$5.17
EPS YoY Growth
780.00%
Balance Sheet (FY 2025)
Total Assets
$17.57M
Total Liabilities
$161.92M
Stockholders' Equity
$405.31M
Current Assets
$17.57M
Current Liabilities
$161.92M